Drug-Free Obesity Capsule Cleared; FDA Reviews Acromegaly Tx; Stem Cells Reverse T1D

The FDA cleared a drug-free capsule for weight management in adults with a BMI of 25-40, said maker Epitomee Medical. Once swallowed, the capsule absorbs water in the stomach and creates a three-dimensional matrix to occupy volume, creating a sensation of fullness.

Ascensia Diabetes Care said its 1-year Eversense 365 continuous glucose monitor is now available in the U.S.

Crinetics Pharmaceuticals submitted a new drug application to the FDA for its investigational once-daily oral acromegaly treatment paltusotine.

A woman in China had her type 1 diabetes effectively reversed with a transplant of her own reprogrammed stem cells. (Nature)

Over 9% of bariatric surgery patients showed at least hazardous/harmful alcohol consumption on the Alcohol Use Disorders Identification Test, according to a study of linked health claims and survey data. (International Journal of Obesity)

In a study of 90 patients with central precocious puberty, (epi)genetic causes were identified in 12.2%, indicating that testing for certain genetic defects should be considered. (Journal of Clinical Endocrinology & Metabolism)

Among adolescents and young adults, preconception prediabetes was tied to a 2.21-fold increased risk of gestational diabetes at first live birth, as well as small increases in risk for both pregnancy hypertension and preterm delivery, a retrospective study suggested. (JAMA Network Open)

Ellen DeGeneres, 66, revealed she has osteoporosis. (People)

This Iowa teen and her mother travel 450 miles for gender-affirming care. (NPR)

The WHO is currently developing new guidelines for the management of obesity in children ages 0 to 9.

Women who slept less than 7 hours per night at 24 to 28 weeks’ gestation were more likely to have a neurodevelopmentally delayed child versus those sleeping 7 hours or more per night, according to a prospective cohort study. (Journal of Clinical Endocrinology & Metabolism)

Please enable JavaScript to view the comments powered by Disqus.